AI capabilities are advancing exponentially while policy and legislation lag years behind, creating a dangerous gap. This article argues for binding, FAA-style regulation of frontier models, plus updates to tax, innovation, social power balance, and geopolitical strategies to keep pace.

• AI capabilities went from barely coherent code to handling most software work at top AI firms in four years, tracking scaling laws that predict continued exponential gains
• Frontier models already pose real threats to cybersecurity, finance, critical infrastructure and national security (e.g. the Claude Mythos Preview breach), with bio and autonomy risks likely next
• Voluntary disclosure and optionality-preserving measures (transparency rules, export controls) are no longer sufficient given these demonstrated risks
• Anthropic will back binding federal pre-deployment testing requirements for frontier AI plus job-displacement policy, modeled on an FAA-style certification and audit system, building on early state laws like California's SB 53, New York's RAISE act and Illinois's SB 315

State AI laws face constitutional limits under the dormant Commerce Clause, but courts lack the data to weigh interstate burdens against local benefits. The article argues policymakers must build evidentiary records—through standardized burden and benefit estimates—and equip judges with analytical tools for effective cost-benefit review.

• Over 1,500 AI bills across 45 states this year are creating a dormant Commerce Clause crisis, but judges have no standardized data to run the required Pike balancing test weighing interstate burdens against local benefits.
• This evidence gap hits startups hardest since large platforms can absorb compliance costs across a patchwork of state rules while smaller firms can't—illustrated by xAI's new lawsuit against Colorado's AI Act.
• The White House Executive Order's Commerce Department review and DOJ task force on state AI laws will generate some data but won't close the gap alone.
• Fixing this requires mandated impact analyses with consistent metrics for proposed state AI rules, plus judicial tools like checklists, model findings, or a benchbook to help courts actually apply the evidence.

The EU's new GMP Annex 22 regulation requires pharmaceutical companies to use fully validated and deterministic AI models in manufacturing. ValidTrace offers a solution by providing pre-validated AI models that meet these compliance standards, ensuring predictable outputs critical for the industry.

• EU's GMP Annex 22 now requires AI used in pharma manufacturing to be fully validated and deterministic, ruling out standard AI's variable outputs for identical inputs.
• ValidTrace sells pre-validated, deterministic AI models plus audit-ready decision logs to turn this compliance burden into a ready-made product.
• Revenue model combines tiered API access, annual model licenses, and enterprise support, with a free "GMP AI Readiness Grader" and open-source library as customer-acquisition hooks.
• Competitive moat is workflow integration/lock-in rather than the models themselves, making switching costly for customers.